Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Two-year collaboration aims to strengthen primary healthcare systems, generate real-world evidence, and support responsible adoption of AI and digital health technologies across South-East Asia
The regulatory decision follows promising results from RIVER-81
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.
Subscribe To Our Newsletter & Stay Updated